VANCE J BRAY MD
NPI 1568456127
Internal Medicine - Rheumatology in Denver, CO

Active since September 09, 2005
91.11/100
CMS Quality Rating
7111 E LOWRY BLVD STE 200, DENVER, CO 80230(303) 394-2828(303) 320-0242 Get Directions Write a Review

NPPES record last updated: September 6, 2023. Verified against the NPPES registry weekly; last sync: November 15, 2026.

Record update history: Sep 6, 2023, Jan 24, 2023, Mar 23, 2021 (3 updates tracked since 2021).

About Vance J Bray Md NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

VANCE J BRAY MD (NPI 1568456127) is an individual rheumatology provider in Denver, Colorado, licensed in Colorado (29019) and active in the NPI registry since September 2005.

NPPES Registry Identity

NPI1568456127
Entity TypeIndividualMale
Primary Taxonomy207RR0500X
Provider Legal NameVANCE J BRAYCredential: MD
Location Address7111 E LOWRY BLVD STE 200Denver, CO 80230-7360
Mailing Address7111 E Lowry Blvd Ste 200Denver, CO 80230-7360 · (303) 394-2828 · Fax (303) 320-0242
Fax(303) 320-0242
Sole ProprietorNo
Enumeration DateSeptember 9, 2005
Last NPPES UpdateSeptember 6, 20233 updates tracked since enumeration
NPPES CertifiedSeptember 6, 2023
✔ NPI 1568456127 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

★ Primary SpecialtyInternal Medicine · RheumatologyAllopathic & Osteopathic Physicians
Taxonomy Code207RR0500X
License✔ Licensed in CO · 29019
Definition
An internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases.
7111 E LOWRY BLVD STE 200, Denver, CO 80230

Other Identifiers 2

Medicaid01290196CO
OtherBR73794CO · Blue Cross Blue Shield

Areas of Expertise CMS Part B claims 28

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, tocilizumab, 1 mg J3262
Tocilizumab is a medication administered via injection. It's used to treat certain conditions like rheumatoid arthritis by reducing inflammation in the body. It works by blocking a substance in the body that leads to inflammation.
20,960 services11 patients
Injection, golimumab, 1 mg, for intravenous use J1602
Golimumab is a medication given through an IV (a small tube in your vein). It helps to reduce inflammation and pain by blocking a protein in your body that causes inflammation. It's often used to treat conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
19,650 services38 patients
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) J0129
Abatacept is a medication administered via injection under a doctor's supervision. It's used to treat conditions like rheumatoid arthritis by moderating the immune system. This code applies when the doctor administers the drug, not for self-administration.
10,825 services43 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
10,440 services125 patients
Injection, romosozumab-aqqg, 1 mg J3111
Romosozumab-aqqg is a medication given by injection to treat osteoporosis in patients at high risk for fractures. It works by increasing bone mass and strength, reducing the risk of fractures.
3,990 services11 patients
Injection, infliximab, excludes biosimilar, 10 mg J1745
Infliximab is a medication given via injection to treat certain autoimmune conditions. It works by blocking the action of a substance in your body that causes inflammation. Each dose is based on your medical condition and response to treatment.
3,450 services26 patients

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

91.11/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality90.23
Promoting Interoperability88
Improvement Activities40
Cost73.49

Reported Quality Measures

Clinical Information Reconciliation
For at least one transition of care or referral received or patient encounter in which the MIPS eligible clinician has never before encountered the patient, the MIPS eligible clinician performs clinical information reconciliation.
99%72 patients4/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
100%2,656 patients5/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
89%1,999 patients4/55-star benchmark: 100%
Osteoarthritis (OA): Function and Pain Assessment
Percentage of patient visits for patients aged 21 years and older with a diagnosis of osteoarthritis (OA) with assessment for function and pain
52%1,330 patients3/55-star benchmark: 100%
Pain Assessment and Follow-Up
Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present
71%2,644 patients3/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from certified EHR technology to identify patient-specific educational resources and provide electronic access to those materials to at least one unique patient seen by the MIPS eligible…
13%585 patients1/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
61%646 patients3/55-star benchmark: 90%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous…
94%1,362 patients4/55-star benchmark: 97%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
95%62 patients4/55-star benchmark: 100%
Provide Patient Access
For at least one unique patient seen by the MIPS eligible clinician: (1) The patient (or the patient authorized representative) is provided timely access to view online, download, and transmit his or her health information; and (2) The MIPS eligible clinician…
15%585 patients1/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months
95%639 patients4/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Functional Status Assessment
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 months
95%639 patients4/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Glucocorticoid Management
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >= 10 mg daily (or equivalent) with improvement or no change in disease…
75%639 patients3/55-star benchmark: 100%
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease activity within 12 months
94%639 patients4/55-star benchmark: 100%
Screening for Osteoporosis for Women Aged 65-85 Years of Age
Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis
97%429 patients5/55-star benchmark: 97%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of certified EHR technology to the patient (or the patient-authorized representative), or in…
63%585 patients4/55-star benchmark: 77%
Use of High-Risk Medications in the Elderly
Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication.
Lower rates are better for this measure.
Patients 2+: 2% · 646 patients
6%646 patients3/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 14

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Specialist
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230
Internal Medicine (Rheumatology)
7111 E LOWRY BLVD STE 200
DENVER, CO 80230

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Vance Bray's NPI number?

The NPI number for Vance Bray is 1568456127. It was assigned to this individual provider in the NPPES registry on September 9, 2005.

Where is Vance Bray located?

Vance Bray practices at 7111 E Lowry Blvd Ste 200, Denver, CO 80230. The listed phone number is (303) 394-2828.

What is Vance Bray's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Rheumatology, with taxonomy code 207RR0500X.

When was this NPI record last updated?

The NPPES record for Vance Bray was last updated on September 6, 2023. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 3 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.